BioPharma Reporter: Synthetic biology innovator opens new campus to speed up drug discovery
Oct 21, 2021
BioPhama Reporter’s Jane Byrne covered Absci’s recently opened campus in Vancouver, Washington and spoke to founder and CEO Sean McClain about optimizing the drug candidate prediction process as well as Absci’s alliance with EQRx.
Read the full article from BioPharma Reporter here:
www.absci.com/biopharmareporter-new-HQ